The Outset Closed the Day rhode Opened in Europe
Five products, priced $32 to $54, and 500 Sephora doors by April 2022 — one month after launch. That was The Outset, which announced it was winding down on 29 September 2026. The next day rhode opened in more than 500 Sephora doors across 19 European markets. rhode had ten products and no retail at all when e.l.f. Beauty paid $1 billion for it. Scarlett Johansson is the more famous woman. She got to the shelf first, too.
What happened in the last week of September?
The Outset's notice was short. It had decided to wind down operations, the brand said, after an incredible journey. Shopping closed. Orders already placed would still ship. Scarlett Johansson and Kate Foster Lengyel had started the brand in March 2022, which put it at four and a half years old when it stopped.
rhode's announcement went the other direction entirely. Nineteen European markets at once — France, Germany, Italy, Spain, Poland, Sweden, Switzerland, Turkey and eleven more — across more than 500 Sephora doors and the retailer's own site, with two new ranges, Pocket Bronze and Highlight Milk, arriving alongside the core line.
The two have nothing to do with each other. Retail rollouts get locked months ahead; wind-downs get decided in board rooms, not in response to a rival's press release. But the accident is useful, because it sets up a comparison nobody could have arranged on purpose. Two beauty brands, both started by famous women within three months of each other in 2022, both skincare-led, both built for an American shopper first. Same week, opposite ends of the industry.
Did the smaller name really beat the bigger one?
Not in any sense a publicist would recognise. Johansson has twenty years of films behind her and an audience that predates Instagram. The Outset's own channels finished at roughly 438,000 followers on Instagram and about 610,000 on TikTok — a perfectly decent brand account, and nowhere near what its founder draws personally.
The rest of the casualty list doesn't sort by fame either. Gwen Stefani's GXVE Beauty went in February 2026. Drew Barrymore's Flower Beauty went in September 2025, Kate Moss's Cosmoss three months before that, and Kate Hudson's InBloom belongs on the same list. Nobody here was short of recognition.
So fame isn't the variable. Something else is doing the sorting.
What did The Outset buy with its first cheque?
Najafi Companies put in somewhere between $5 million and $10 million, with Beliade and Plus Capital alongside. The firm's founder said at the time that the point wasn't to bring another brand to market with a celebrity face on it.
What the money bought was shelf space, a great deal of it, very fast. Five hundred Sephora doors in April 2022 is where most independent brands hope to arrive in year five. The Outset was there in month two, before anybody had bought the same product twice.
That is not a prize you keep. Doors come with a number attached — sell-through per door per week — and the number gets reviewed on a schedule. Miss it and you lose facings, then shelves, then the account. The Outset grew from five products to around fourteen, came out of Sephora, and ended up scattered across Amazon, Nordstrom, QVC, Revolve, Goop, Credo and Cult Beauty. Third-party estimates put 2025 sales somewhere between $10 million and $25 million. Projections circulating at launch had put year one at $10 million. So: four and a half years of work, and the number had barely moved.
What did rhode refuse to do for three years?
One website. That was the whole distribution plan from 2022 until autumn 2025 — no Sephora, no Ulta, no Amazon, no wholesale of any kind, and ten products.
Refusing retail is expensive. There's no store traffic to convert, so the brand has to manufacture its own demand every week, from nothing. What it buys in exchange is a customer list the brand owns outright and full gross margin with nobody taking a wholesale cut. It also buys something less obvious: no review date. rhode could spend as long as it liked working out which products people came back for, because nobody was going to pull its facings while it did.
Retail arrived later, on rhode's terms. Sephora in the US and Canada in autumn 2025, the UK by year end, Europe in 2026. The company now calls rhode the top beauty brand at Sephora in North America and the UK.
Same retailer, opposite order — and the order is the argument.
What is ten products worth, and what is $350 million worth?
e.l.f. Beauty agreed in May 2025 to pay $1 billion for rhode: $800 million at closing, up to $200 million more as a three-year earnout, funded with $600 million of committed debt and $200 million in newly issued shares. Behind that price sat $212 million of net sales over the prior twelve months, from ten products, sold direct.
Now set Rare Beauty beside it. Launched September 2020 through Sephora. Revenue above $350 million a year. Bankers hired, $2 billion asked for. The process was reported on hold in September 2024, with buyers unwilling to pay a premium for a brand leaning on one celebrity and one product line.
More revenue, smaller price. That isn't a comparison anyone makes out loud at a conference, but read the two deals together and the logic is hard to miss. What a buyer pays for is the share of the business that survives the founder going quiet.
Why did buyers stop paying for celebrity?
Because of what a famous founder actually delivers, which is narrower than it looks from outside. Two things, reliably. A very loud first week, and a meeting with a retail buyer that other brands queue years for. Both land at the front, and neither builds on itself. Attention falls away from launch day unless something keeps feeding it, and the retail door, the moment it opens, stops being an asset and becomes a quota.
Miss the quota and you're carrying the cost base of a company you never became. Which brings the Najafi line back around. The stated plan was not to stick a celebrity on a brand, and what came out was clean, vegan, allergen-free skincare for sensitive skin — a shelf several hundred other brands are already standing on. The face was unlike anyone else's. The serum wasn't.
What does a four-year brand cost its manufacturer?
None of these companies owns a factory. The products get developed and filled by contract manufacturers, a lot of them Korean ODM houses — the firms that build a formula for a client to put its own name on.
The supplier carries the risk, and carries it first. A brand opening in 500 doors has to fill 500 doors, which makes that opening order the largest single PO anyone in the relationship will ever see. It lands before a single unit has sold through. The supplier is, in effect, lending working capital against a hypothesis. Whether a second order follows depends on a planogram review nobody from the factory attends, and nobody from the factory hears about it until the orders stop.
And they stop quietly. There's no termination letter when a brand loses facings. There's a quarter where the forecast simply doesn't convert.
Four brands in this bracket shut between June 2025 and September 2026. Read from Seoul, that isn't a story about celebrity culture. It's a receivables question, and the answers are the dull ones any concentrated-customer business already knows: MOQs written into the agreement, payment terms that don't quietly fund somebody else's launch, tooling and formulation billed up front rather than amortised across volume nobody has committed to.
Is the celebrity brand model finished?
Hardly, and the same week says so. rhode is a celebrity brand, and it just opened nineteen markets. Rare Beauty is a celebrity brand doing north of $350 million. What died is the lazy version of it — the one that treats a founder's name as a replacement for the work instead of a head start on it.
The question a buyer asks now fits in a line: would this still sell if she stopped posting? rhode had an answer, in the form of ten products people reordered. The Outset never produced one. Half-price discounting in the weeks before the announcement is what not having an answer looks like on a price list.
Where does this leave the three parties?
Manufacturers and ODM suppliers. The exposure is the opening order, not the founder. A brand that starts at full distribution buys big, buys early and can stop on no notice at all. Price the first PO as though it's the last one, because sometimes it is.
Brands and the buyers who stock them. An invitation accepted too early converts a growth option into a quota. Settle before signing whether the brand can hold the space on its own pull, with the retailer's footfall taken out of the calculation.
Investors. Revenue quality is being priced out loud now. Two hundred and twelve million dollars a brand owned outright was worth a billion. Three hundred and fifty million routed through somebody else's shelf wasn't worth two.
Distribution doesn't make demand. It invoices for it.
Comments